首页> 外文OA文献 >EP1.14-43 The Safety of First-line and Subsequent Monotherapy of PD-1/PD-L1 Inhibitors in NSCLC: A Meta Analysis

【2h】

EP1.14-43 The Safety of First-line and Subsequent Monotherapy of PD-1/PD-L1 Inhibitors in NSCLC: A Meta Analysis

机译：EP1.14-43 NSCLC中PD-1 / PD-L1抑制剂PD-1 / PD-L1抑制剂的一线和随后的单药治疗的安全性：META分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Y. Yang; Z. Xie; P. Pang; N. Wang; H. Liang; L. Zhao;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Effectivity and safety of PD-1/PD-L1 inhibitors for different level of PD-L1-positive, advanced NSCLC: A meta-analysis of 4939 patients from randomized controlled trials [J] . International immunopharmacology . 2020,第期

机译：PD-1 / Pd-L1抑制剂对不同水平PD-L1阳性，高级NSCLC的影响和安全性：4939例随机对照试验的荟萃分析
2. Effectiveness and safety of PD-1/PD-L1 or CTLA4 inhibitors combined with chemotherapy as a first-line treatment for lung cancer: A meta-analysis [J] . Kaikai Shen, Jinggang Cui, Yuqing Wei, Journal of Thoracic Disease . 2018,第12期

机译：PD-1 / PD-L1或CTLA4抑制剂联合化疗作为肺癌一线治疗的有效性和安全性：荟萃分析
3. Innovative immunotherapy targeting at PD-1/PD-L1 signaling pathway: mechanism, efficacy and safety analysis of monotherapy and combination therapies in non-small cell lung cancer (NSCLC) treatment [J] . Zhixuan Song, Yimiao Lin E3S Web of Conferences . 2021,第a期

机译：靶向PD-1 / PD-L1信号通路的创新免疫疗法：非小细胞肺癌（NSCLC）治疗中单药治疗和组合疗法的机制，疗效和安全分析
4. Multiparametric Flow Cytometry Analysis of Checkpoint Inhibitors (PD-1 and PD-L1) in Dissociated Tumor and Normal Tissues [C] . Shawn P. Fahl International Molecular Medicine Tri-Conference. . 2019

机译：离聚肿瘤和正常组织中检查点抑制剂（PD-1和PD-L1）的多次流式细胞术分析
5. PD-1/PD-L1 antibodies efficacy and safety versus docetaxel monotherapy in advanced NSCLC patients after first-line treatment option: systems assessment [O] . Qiang Su, Zhigang Sun, Chenguang Zhang, 2017

机译：一线治疗选择后的晚期NSCLC患者PD-1 / PD-L1抗体与多西他赛单药治疗的疗效和安全性：系统评估
6. Hepatotoxicity in patients with solid tumors treated with PD-1/PD-L1 inhibitors alone, PD-1/PD-L1 inhibitors plus chemotherapy, or chemotherapy alone: systematic review and meta-analysis [O] . Xiaodi Guo, Wendong Li, Jiexuan Hu, 2020

机译：单独使用PD-1 / PD-L1抑制剂治疗固体肿瘤的肝毒性，PD-1 / PD-L1抑制剂加上化疗，或单独化疗：系统评价和荟萃分析

EP1.14-43 The Safety of First-line and Subsequent Monotherapy of PD-1/PD-L1 Inhibitors in NSCLC: A Meta Analysis

著录项

引文网络

相似文献

相关主题

期刊订阅